# A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine

> **NCT00844207** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 40 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Fixed combination of Azithromycin and Chloroquine
- **DRUG:** Azithromycin and Chloroquine

## Key facts

- **NCT ID:** NCT00844207
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2009-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00844207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00844207, "A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00844207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*